Episodes 46-60 of 123
APOC3 Inhibition: A Novel Approach to Lowering TGs
MinuteCE®APOC3 Inhibition: A Novel Approach to Lowering TGs
Latest Clinical Trial Outcomes and Breakthroughs for FCS
MinuteCE®Latest Clinical Trial Outcomes and Breakthroughs for FCS
SHTG: Decoding the Latest Clinical Trial Outcomes
MinuteCE®SHTG: Decoding the Latest Clinical Trial Outcomes
Remnant Cholesterol: The Missing Link in ASCVD risk
MinuteCE®Remnant Cholesterol: The Missing Link in ASCVD risk
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
MinuteCE®Targeting Mixed Hyperlipidemia with APOC3 Inhibition
- advertisement
The Road Ahead: What's on the Horizon for FCS and SHTG Management
MinuteCE®The Road Ahead: What's on the Horizon for FCS and SHTG Management
Obesity: Unmasking the Chronic Disease Beneath the Weight
MinuteCE®Obesity: Unmasking the Chronic Disease Beneath the Weight
Obesity and Comorbidities: Strategies for Effective Patient Management
MinuteCE®Obesity and Comorbidities: Strategies for Effective Patient Management
Treating Obesity: Lifelong Strategies from Lifestyle to Pharmacotherapy and Surgery
MinuteCE®Treating Obesity: Lifelong Strategies from Lifestyle to Pharmacotherapy and Surgery
Beyond the Scale: How to Tackle Obesity’s Comorbidities
MinuteCE®Beyond the Scale: How to Tackle Obesity’s Comorbidities
- advertisement
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
CME/CEDriving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
CME/CECracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
CME/CEEstablishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers























































